The Class Ltd (ASX: CL1) share price fell 7% in early trade on Thursday morning following an ASX update to shareholders.
Class is a software company which specialises in products for financial advisers and self-managed superannuation funds (SMSFs). These are called the Class Portfolio And Class Super, respectively.
In its press release, Class reported that its total accounts rose 1,760 to 174,212 and its total number of customers rose by 57 to 1,470.
The company’s core product, Class Super, added 1,529 accounts despite the reduction of 1,000 AMP Limited (ASX: AMP) accounts.
“The lower than expected growth in accounts reflects regulatory uncertainty, increased competition and a lower number of average accounts per new customer,” Class’ update read.
To get back to a leadership position in the market, Class said it will release new features and make it even simpler for accountants and advisers to manage Super funds for their clients.
Class Portfolio’s total accounts rose to 6,581 with 32% of Class Super customers now using Class Portfolio.
Class recently launched a managed accounts service and has already signed OpenInvest and InvestSMART Group Ltd (ASX: INV) as partners. The company says this is a potential growth driver.
Class said its annualised recurring revenue (ARR) from licence fees for its products rose 10.1% to $37.1 million, as at 31 December 2018. Excluding the loss of AMP advisers, a transition which has been well foreshadowed, Class says it has a customer retention rate of 99.2%.
Unfortunately for Class shareholders, the company is yet to finalise its search for a new CEO. However, it says it is in the final stages of the recruitment efforts and expects to announce the successful candidate before it reports its financial results in February.
Thinking of Buying Class Shares? Read This First…
After searching through a market with over 2,000 shares, our expert investment analyst has narrowed it down to just 2 of his favourite rapid-growth shares in a FREE report to Rask Media readers.
Over the past five years, these two shares have gone from being 'tiny caps' to being serious contenders for the ASX 200.
Idea #1 is taking on the world, starting with the huge USA market. In a just a few short years the company has snatched market share away from rivals and is on its way to being the market leader.
Idea #2 uses a 'printer and cartridge' type model to get large and established customers: a) using their healthcare industry-leading product, b) paying for it again and again and again... so it's little wonder this company is tipped to grow at a rapid pace in 2019.
Access the free report by clicking here now. Absolutely no credit card or payment details required.
Disclaimer: Any information contained in this article is limited to general financial/investment advice only. The information has not taken into account your specific needs, goals or objectives, so please consider consulting a licenced and trusted adviser before acting on the information. Please read The Rask Group’s Financial Services Guide (FSG) for more information. This article is authorised by Owen Raszkiewicz of The Rask Group, which is a corporate authorised representative No. 1264179 of Strawman Pty Ltd (ACN: 610 908 211) (AFSL: 501 223).